Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4214.16 | 458 / 459 | 97% | 55.96 | 1086 / 1118 |
thymus | 100% | 17453.33 | 653 / 653 | 95% | 111.34 | 576 / 605 |
kidney | 100% | 5924.03 | 89 / 89 | 94% | 32.45 | 845 / 901 |
liver | 100% | 8879.12 | 226 / 226 | 90% | 43.64 | 365 / 406 |
ovary | 99% | 3713.93 | 179 / 180 | 90% | 37.42 | 385 / 430 |
lung | 100% | 6565.03 | 578 / 578 | 89% | 35.16 | 1027 / 1155 |
esophagus | 99% | 3236.87 | 1432 / 1445 | 89% | 30.17 | 163 / 183 |
pancreas | 94% | 2204.86 | 307 / 328 | 92% | 44.69 | 164 / 178 |
uterus | 100% | 3657.34 | 170 / 170 | 81% | 23.64 | 370 / 459 |
bladder | 100% | 5478.67 | 21 / 21 | 77% | 29.02 | 387 / 504 |
skin | 79% | 2184.57 | 1423 / 1809 | 94% | 42.95 | 446 / 472 |
stomach | 99% | 4037.54 | 357 / 359 | 66% | 15.02 | 190 / 286 |
adrenal gland | 100% | 7186.42 | 258 / 258 | 54% | 19.42 | 125 / 230 |
intestine | 87% | 2142.91 | 838 / 966 | 53% | 13.59 | 278 / 527 |
prostate | 96% | 2869.17 | 236 / 245 | 37% | 5.81 | 186 / 502 |
brain | 67% | 1156.44 | 1771 / 2642 | 40% | 5.53 | 283 / 705 |
adipose | 100% | 5970.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 95.62 | 80 / 80 |
muscle | 100% | 8352.37 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6408.14 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.35 | 1 / 1 |
heart | 99% | 10099.41 | 849 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 4381.86 | 1300 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 4683.29 | 895 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 25.88 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 84% | 21.02 | 38 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010706 | Biological process | ganglioside biosynthetic process via lactosylceramide |
GO_0016266 | Biological process | O-glycan processing |
GO_0002319 | Biological process | memory B cell differentiation |
GO_0018146 | Biological process | keratan sulfate biosynthetic process |
GO_0097503 | Biological process | sialylation |
GO_1990743 | Biological process | protein sialylation |
GO_0036211 | Biological process | protein modification process |
GO_0019082 | Biological process | viral protein processing |
GO_0006054 | Biological process | N-acetylneuraminate metabolic process |
GO_1905403 | Biological process | negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006486 | Biological process | protein glycosylation |
GO_1990675 | Cellular component | Golgi medial cisterna membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_1990676 | Cellular component | Golgi trans cisterna membrane |
GO_0008373 | Molecular function | sialyltransferase activity |
GO_0047288 | Molecular function | beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase |
GO_0003836 | Molecular function | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity |
Gene name | ST3GAL1 |
Protein name | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (Alpha 2,3-ST 1) (Beta-galactoside alpha-2,3-sialyltransferase 1) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (SIATFL) (ST3Gal I) (ST3GalI) (ST3GalA.1) (ST3O) (Sialyltransferase 4A) (SIAT4-A) beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3-sialyltransferase (EC 2.4.3.2) (Monosialoganglioside sialyltransferase) |
Synonyms | SIAT4 SIAT4A |
Description | FUNCTION: A beta-galactoside alpha2-3 sialyltransferase involved in terminal sialylation of glycoproteins and glycolipids . Catalyzes the transfer of sialic acid (N-acetyl-neuraminic acid; Neu5Ac) from the nucleotide sugar donor CMP-Neu5Ac onto acceptor Galbeta-(1->3)-GalNAc-terminated glycoconjugates through an alpha2-3 linkage . Adds sialic acid to the core 1 O-glycan, Galbeta-(1->3)-GalNAc-O-Ser/Thr, which is a major structure of mucin-type O-glycans. As part of a homeostatic mechanism that regulates CD8-positive T cell numbers, sialylates core 1 O-glycans of T cell glycoproteins, SPN/CD43 and PTPRC/CD45. Prevents premature apoptosis of thymic CD8-positive T cells prior to peripheral emigration, whereas in the secondary lymphoid organs controls the survival of CD8-positive memory T cells generated following a successful immune response (By similarity). Transfers sialic acid to asialofetuin, presumably onto Galbeta-(1->3)-GalNAc-O-Ser (By similarity). Sialylates GM1a, GA1 and GD1b gangliosides to form GD1a, GM1b and GT1b, respectively (By similarity). . |
Accessions | ENST00000648219.1 ENST00000523855.1 E5RH34 Q11201 ENST00000519924.5 E5RGI3 E5RG72 ENST00000522652.6 ENST00000523854.5 ENST00000523634.1 ENST00000521180.5 E5RHV6 ENST00000517668.5 E5RGL4 |